Peter T. Slover's most recent trade in Contineum Therapeutics Inc. - Ordinary Shares - Class A was a trade of 192,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Contineum Therapeutics Inc (Class A) | Peter T. Slover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 192,000 | 192,000 | - | - | Stock Option (right to buy) | |
| Contineum Therapeutics Inc (Class A) | Peter T. Slover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Contineum Therapeutics Inc (Class A) | Peter T. Slover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |